Tower Research Capital (TRC)’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$869K Buy
9,854
+8,305
+536% +$711K 0.01% 1158
2026
Q2
$120K Sell
1,549
-886
-36% -$64.6K ﹤0.01% 2046
2026
Q1
$159K Sell
2,435
-2,244
-48% -$167K ﹤0.01% 1803
2025
Q4
$371K Buy
4,679
+3,034
+184% +$232K 0.01% 1011
2025
Q3
$120K Buy
1,645
+148
+10% +$10.8K ﹤0.01% 1855
2025
Q2
$114K Sell
1,497
-3,617
-71% -$256K ﹤0.01% 2276
2025
Q1
$389K Sell
5,114
-1,617
-24% -$120K 0.01% 992
2024
Q4
$445K Buy
6,731
+2,804
+71% +$196K 0.01% 1150
2024
Q3
$274K Sell
3,927
-2,685
-41% -$161K 0.01% 1333
2024
Q2
$350K Buy
+6,612
New +$401K 0.01% 1632

Other funds holding SOLV

Tower Research Capital (TRC)'s SOLV Position: Q3 2026 in Review

Tower Research Capital (TRC) increased its Solventum (SOLV) stake by 536% in Q3 2026, buying an estimated $711K and bringing the position to 9,854 shares worth $869K. The position accounts for 0.01% of the portfolio, ranked #1158.

Tower Research Capital (TRC) first reported a position in SOLV in Q2 2024 and has held it in 10 quarters since. 897 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • Tower Research Capital (TRC) held 9,854 shares of Solventum worth $869K as of Q3 2026.
  • Tower Research Capital (TRC) bought 8,305 Solventum shares in Q3 2026, an estimated $711K.
  • Solventum made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #1158 holding.
  • Tower Research Capital (TRC) first reported a position in Solventum in Q2 2024 and has held it in 10 quarters since.
  • 897 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.